Thus, it must be confirmed whether or not GAL plays an important role in breast cancer, and the proliferative/antiproliferative action of the peptide in bladder cancer, melanoma and cardiac and esophageal carcinomas must be investigated in-depth. Here, GAL is linked to breast carcinoma.